Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DZIP3 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
mRNA | NONO | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | SGTB | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | UBTF | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
mRNA | PKP3 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-06 |
mRNA | SLC11A1 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | GSDMA | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | TYROBP | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | BAIAP2 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
mRNA | DAZAP2 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |